Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) has provided an announcement.
Lifecare ASA is a medical sensor developer specializing in advanced continuous glucose monitoring solutions based on osmotic pressure technology, with applications across human and veterinary health. The company has announced that Teigland Eiendom AS, a company closely associated with board member Trine Teigland, has subscribed for 10 million new shares in Lifecare’s ongoing partially underwritten rights issue at NOK 0.50 per share through the exercise of subscription rights, and simultaneously subscribed for 15 million associated warrants split between two series with exercise windows in March and June 2026. The substantial participation by an insider-related entity signals internal confidence in the capital raise and supports the company’s financing efforts, which are important for advancing its sensor technologies and strengthening its position in the medical diagnostics market.
More about Lifecare AS
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring various body analytes, with a primary focus on bringing next-generation continuous glucose monitoring (CGM) systems to market. Leveraging osmotic pressure as its core sensing principle, Lifecare’s sensor technology is designed to detect and monitor a broad range of analytes and molecules in humans and pets, positioning the company within the advanced medical diagnostics and digital health space.
Average Trading Volume: 542,265
Current Market Cap: NOK157.7M
For an in-depth examination of LFC0 stock, go to TipRanks’ Overview page.